Our results identified that lincROR exerted a significant effect on tumorigenesis through activating the WNT/β-catenin signalling, which made us to speculate a close association between lincROR expression and the CRC patients with abnormally high WNT signalling activation, namely CMS2 patients. The gene discussed is LINC-ROR; the disease is colorectal carcinoma.